Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593968-20-002246
Filing Date
2020-11-24
Accepted
2020-11-24 16:29:07
Documents
1
Period of Report
2020-11-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4  
1 PRIMARY DOCUMENT primary_01.xml 4 4561
  Complete submission text file 0001593968-20-002246.txt   6040
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Issuer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2658 DEL MAR HEIGHTS RD., #555 DEL MAR CA 92014
Business Address
Marguglio David J. (Reporting) CIK: 0001461753 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36242 | Film No.: 201344527